• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Mackenzie's Mission HomepageMackenzie's Mission

DONATE Mackenzies Mission Donate
  • Mission
  • About
    • The Story
    • Board
  • Resources
    • Resource List
    • What Is Amyloidosis
  • Speakers Bureau
    • About ASB
    • ASB Operating Committee
  • Fundraisers
  • Blog
  • Contact

amyloidosis news

Int’l Symposium on Amyloidosis (ISA) – Heidelberg 2022

September 12, 2022

We are super proud to have presented the story about the Amyloidosis Speakers Bureau at last week’s International Symposium on Amyloidosis (ISA) in Heidelberg, Germany. 

Filed Under: Featured News, Speakers Bureau News Tagged With: amyloidosis, amyloidosis diagnosis, amyloidosis news, amyloidosis speakers bureau, diagnosing amyloidosis, patientsteachingstudents, speakers bureau news

Hereditary Amyloidosis Among Portuguese Americans

March 11, 2022

Americans of Portuguese descent are disproportionately impacted by hereditary ATTR (hATTR) amyloidosis, a rare, rapidly progressive, and debilitating disease affecting multiple organs and tissues. Watch this informative news segment featuring Dr. Anthony Geraci, a neurologist who specializes in managing hATTR amyloidosis. He is joined by Julio, who was diagnosed with the disease a few years ago, and his daughter and caregiver Renee. Together they explore the experience of living with this rare, genetic disease.

Filed Under: Featured News, What Is Amyloidosis Tagged With: amyloidosis, amyloidosis news, ATTR amyloidosis, diagnosing amyloidosis, hATTR, Hereditary Amyloidosis

CRISPR/Cas9 – Editing the Code of Life

March 20, 2021

The scientific world is abuzz … a Nobel Prize-winning technology called CRISPR/Cas9 can now edit our DNA. This programmable gene-editing technology, which is efficient, precise, and scalable, has inspired a gold rush of countless applications in medicine, agriculture and basic science.  In this blog we invite you to read more about this ground-breaking advance and how, with one course of treatment, it could potentially cure hereditary transthyretin (hATTR / ATTRv) amyloidosis.

Filed Under: Featured News, What Is Amyloidosis Tagged With: #clinicaltrials, #crispr, #crispr/cas9, amyloidosis, amyloidosis clinical trials, amyloidosis news, amyloidosis treatment, ATTR amyloidosis, attrv, hATTR, Hereditary Amyloidosis, hereditaryamyloidosis

AI, Protein Folding & Amyloidosis

February 18, 2021

AI is rapidly advancing the knowledge of protein misfolding, unlocking answers for amyloidosis which should lead to earlier diagnosis, improved treatment, and better patient survival.

Filed Under: Featured News, What Is Amyloidosis Tagged With: #deepmind, AI, amyloid protein, amyloidosis, amyloidosis diagnosis, amyloidosis news, amyloidosis research, Artificial Intelligence, ATTR amyloidosis, ATTRwt, diagnosing amyloidosis, light chain amyloidosis, Protein Folding, protein misfolding, wild-type amyloidosis

1st FDA-Approved Drug for AL Amyloidosis

January 16, 2021

After decades of relying on treatments approved for other diseases, on January 15, 2021 the FDA approved the first drug for AL Amyloidosis. Truly a game-changing, monumental advancement in the treatment of this disease.

Filed Under: Featured News, What Is Amyloidosis Tagged With: #Andromeda, AL amyloidosis, amyloidosis, amyloidosis clinical trials, amyloidosis news, amyloidosis treatment

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 6
  • Go to Next Page »

Primary Sidebar

Recent News

  • Worldwide Hotspots of Hereditary ATTR Amyloidosis (ATTRv)
  • 2022: Mackenzie’s Mission – Our Report Card
  • CRISPR/Cas9 – ATTR Clinical Trial Update
  • Heart Failure & Amyloidosis
  • Over 10,000 medical students and residents!!

Be A Part Of Our Mission!

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

  • Mission
  • About
  • Resources
  • Speakers Bureau
  • Fundraisers
  • Blog
  • Contact

Registered 501(c)(3) · Contact · Copyright © 2023 · Mackenzies Mission - All Rights Reserved